PRMT5 and lymphoma: Similar to human lymphoma, treatment of canine lymphoma cell lines showed a substantial decrease in global SDMA and H4R3me2s with minimal effect to PRMT5 expression or asymmetric dimethyl arginine (ADMA) as expected with selective inhibition of PRMT5 (Fig 3B and 3C).